Navigation Links
Blood pressure drugs don't protect against colorectal cancer
Date:5/13/2012

A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk.

In recent years, researchers have thought that beta blockers, which are prescribed to many older adults for high blood pressure and heart conditions, might be linked with a decreased risk of cancer. This theory stems from animal and laboratory studies that found that the stress hormone norepinephrine can promote the growth and spread of cancer cells. Beta blockers inhibit norepinephrine's action, so it stands to reason that the medications could have anticancer properties.

Previous studies on beta blockers' effects on colorectal cancer risk have yielded inconsistent results. To provide more thorough information, Michael Hoffmeister, PhD, of the German Cancer Research Center, in Heidelberg, Germany, and his colleagues conducted personal interviews from 2003 to 2007 with 1,762 patients with colorectal cancer and 1,708 cancer-free individuals.

After taking into consideration certain patient characteristics (such as weight and smoking status) and other factors that might influence the results, the researchers found no link between beta blocker use and colorectal cancer risk. Previous studies had not taken these factors into consideration. Even when the investigators broke down their analyses by duration of use of beta blockers, specific types of beta blockers, active ingredients (metoprolol, bisoprolol, carvedilol, and atenolol), and sites within the colon or rectum where colorectal cancer developed, there was no link.

Overall, the results of this study do not support the hypothesis that using beta blockers can lower one's colorectal cancer risk. The findings also point to the importance of considering patient characteristics and other factors that might influence the results of studies that look at how medications affect patients' cancer risk.


'/>"/>
Contact: Amy Molnar
healthnews@wiley.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Blood Clot Risk Linked to Some Non-Pill Contraceptives
2. T-Shirt, Gift Card Giveaways Raise Blood Drives Success
3. Cancer Cells in Bloodstream Show Great Diversity: Study
4. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
5. Liver fat gets a wake-up call that maintains blood sugar levels
6. Study identifies possible protective blood factors against Type 2 diabetes
7. Researchers Rejuvenate Blood-Forming Stem Cells in Mice
8. Whos the Dad? First-Trimester Blood Test May Tell
9. Blood pressure drugs linked with lower PTSD symptoms
10. Researchers determine vitamin D blood level for reducing major medical risks in older adults
11. Can Blood Test Predict Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... , ... The February 13, 2017, assassination of Kim Jong-nam, the half brother ... the deadly use of chemical weapons. Many questions exist about the effect that nerve ... be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of ...
(Date:2/26/2017)... Ireland (PRWEB) , ... February 26, 2017 , ... ... as in 2011 the lab became the world’s first to be ISO/IEC 17025:2005 ... 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... distribution in North America, today announced it would be offering some it’s exclusive ... prides itself on crafting quality and unique baby clothing/feeding products, will team up ...
(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
(Date:2/26/2017)... Miami, Florida (PRWEB) , ... February 26, 2017 ... ... disease (PD) patients after receiving cognitive rehabilitation, according to a study released today ... already known that cognitive rehabilitation programs are proven to be effective in improving ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... STOCKHOLM , Feb 27, 2017 Period October – ... Operating result amounted to SEK -16.4 (-6.4) million ... -0.27 per share (-0.22) before and after dilution Cash flow ... ... amounted to SEK 0.4 (0.4) million Operating result amounted to ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... Forecast to 2025" report to their offering. ... The Global Wireless Health Market ... the next decade to reach approximately $330.5 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:2/24/2017)... and Markets has announced the addition of the "Dry eye Drugs ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... following questions: What are the key drugs ... in the Global Dry eye market? What are the ...
Breaking Medicine Technology: